TIMP-2 was significantly increased in the serum or cerebrospinal fluid (CSF) of stroke, MS, AD, or HD patients, suggesting the protective role of TIMP-2 in neurological disorders [15-17]. This evidence concerns the gene TIMP2 and myeloid sarcoma.